Compounded medications, such as Semaglutide/Cyanocobalamin, are not FDA-approved medications, and FDA does not review compounded medications for safety or efficacy
It's a modern marvel of biochemistry
The table below is the documented dosing reference
The most extensively documented biological effects of BPC-157 in the published research literature are its gastrointestinal cytoprotective properties and with a large body of research from the Sikiric laboratory characterising protection against ethanol-induced gastric lesions, NSAID-induced gastric and intestinal damage, stress-induced ulceration, and inflammatory bowel disease models in rodents
And by doing that, it helps preserve NAD + (key energy carrying molecule), SAM (universal methyl donor), and the downstream processes that depend on them
No severe hypoglycemia or serious treatment-related adverse events reported in trials [1] [2]